Regarding the role of GLP-1 RA in heart failure, some older trials did not show benefits in patients with HFrEF
En el mbito de la biotecnologa avanzada, la retatrutida 10mg es objeto de estudio por su capacidad nica de agonismo triple o GGG
The most commonly reported side effects at therapeutic doses include mild nausea, particularly in the first week of a protocol, which typically resolves by day 7 to 10 without any dose adjustment
Duration is typically short term, with improvement within one to two weeks as the body adapts
Comparing results across trials is imperfect, because the participants were not identical
The identification of probiotic strains, such as DM9218, capable of lowering uric acid levels represents a novel therapeutic avenue